Shares in Stratagene rose 28.8 percent for the four-day trading week ended Tuesday after Agilent signed a deal to buy the firm for $10.94 a share (see related article this issue). The acquisition price represents a 28 percent premium over Stratagene’s closing price the day before the deal was announced.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.